-
Sulfo-Cy5 NHS Ester for Aqueous Biomolecule Labeling
2026-09-23
Sulfo-Cy5 NHS ester supports far-red labeling of amine-containing proteins and ligands in aqueous workflows, including solvent-sensitive samples. Its use in immune-cell and nanomaterial studies is best framed as a way to track a defined labeled biomolecule—not as evidence that the dye labels or changes the activity of phenylalanine nanostructures themselves.
-
Dabigatran Etexilate: Oral Direct Thrombin Inhibition
2026-09-23
Blommel and Blommel’s clinical review describes dabigatran etexilate as an orally absorbed prodrug that produces rapid, predictable anticoagulation through reversible direct thrombin inhibition. Its CYP450-independent activation and metabolism address important limitations of vitamin K antagonists, while renal function, bleeding risk, and gastrointestinal tolerability remain central to research interpretation and dose selection.
-
Metastatic Evolution and CRC Therapy Heterogeneity
2026-09-22
Cho et al. integrated genomic, epigenomic, transcriptomic, and patient-derived xenograft analyses to show how metastatic evolution generates therapeutic heterogeneity in colorectal cancer. The study supports multi-site molecular profiling and functional testing as complementary strategies for interpreting resistance and treatment variability.
-
Lysoptosis: A Conserved Lysosomal Death Pathway
2026-09-22
Luke and colleagues define lysoptosis as a conserved lysosome-dependent cell-death pathway controlled by intracellular serpins, linking lysosomal membrane permeabilization to cathepsin-driven cytoplasmic proteolysis. Their cross-species experiments distinguish this pathway from the secondary lysosomal damage that can accompany apoptosis, necroptosis, ferroptosis, and other regulated cell deaths.
-
S-Adenosylmethionine: Assay Design Beyond Methylation
2026-09-21
Explore how S-adenosylmethionine functions as a methyl donor and assay variable, from DNA and protein methylation to substrate-selective plant enzymes. A MaMT4 case study shows why product identity, enzyme kinetics, and residue-level controls matter when designing SAM-dependent experiments.
-
CCK-8, Opioid Signaling, and Anxiety After Withdrawal
2026-09-21
The reference study shows that cholecystokinin octapeptide reduces anxiety-like behavior during morphine withdrawal through CCK1 receptor activation and endogenous μ-opioid signaling. Its pharmacological design separates CCK receptor involvement from opioid dependence and identifies central CCK1 signaling as a possible mechanistic target for withdrawal-related negative affect.
-
GIGYF2 Drives Hepatic Insulin Resistance via STAU1/PTEN
2026-09-20
Lv et al. identify GIGYF2 as an upstream regulator of obesity-related hepatic insulin resistance, linking it to STAU1-dependent stabilization of PTEN mRNA and suppression of PI3K/AKT signaling. Their combined HepG2-cell and high-fat-diet mouse experiments show how a fluorescent glucose-uptake readout can connect cellular metabolism with a mechanistic RNA-regulatory pathway.
-
I-BET-762: BET Inhibitor Workflow
2026-09-19
I-BET-762 provides a selective way to connect BET-dependent transcription with ferroptosis, LPS-responsive inflammation, and cancer cell vulnerability. This practical guide translates recent BRD4 findings into concentration-matched assays, orthogonal controls, and troubleshooting decisions for reproducible preclinical research.
-
Cholecystokinin Octapeptide Ammonium Assay Guide
2026-09-18
Cholecystokinin octapeptide ammonium enables receptor-aware studies of hippocampal plasticity, neuronal survival, immune signaling, behavior, and ANP secretion. This guide translates the landmark morphine–LTP experiment into practical workflows while addressing the compound’s unusual solubility and sulfation requirements.
-
Pexmetinib (ARRY-614) Cytokine Assay Workflows
2026-09-18
Build more informative inflammation and bone marrow assays with Pexmetinib (ARRY-614), a dual p38 MAPK and Tie2 inhibitor that connects kinase activity to cytokine output. This guide combines practical dosing workflows with structural insights for distinguishing direct pathway inhibition from broader cellular effects.
-
Naloxone hydrochloride in opioid research
2026-09-17
Naloxone hydrochloride provides a fast, reversible way to interrogate opioid receptor signaling in withdrawal, behavior, immune, and neural stem-cell assays. This workflow-focused guide connects antagonist challenge design with the anxiety findings of a morphine-withdrawal study while emphasizing controls, concentration planning, and interpretation limits.
-
Sex Differences in Angiotensin II Hypertension
2026-09-17
Xue, Pamidimukkala, and Hay used telemetry, gonadectomy, baroreflex testing, and ganglionic blockade to show that chronic angiotensin II produces substantially greater hypertension in conscious male than female mice. The study links this divergence to sex-dependent hormonal and autonomic mechanisms, providing a rigorous framework for interpreting cardiovascular experiments beyond resting blood pressure alone.
-
Carbenoxolone disodium: Practical Lab Guide
2026-09-16
Carbenoxolone disodium is an exploratory 11β-hydroxysteroid dehydrogenase inhibitor for studying glucocorticoid access, corticosterone metabolism, and gap junction communication in enzyme, cell, and tissue workflows. It should be used with matched vehicle, viability, and orthogonal pathway controls rather than treated as a selective target-validation reagent or an established in vivo efficacy treatment.
-
MK-0812: Translating CCR2 Biology into MASH Insight
2026-09-16
The gut–liver axis study on intestinal TM6SF2 reframes MASH as a disease shaped by epithelial lipid handling, barrier failure, microbial dysbiosis and hepatic inflammation. This article positions MK-0812 as a research tool for testing the monocyte-trafficking component of that model, while distinguishing evidence-supported pharmacology from hypotheses that require direct validation.
-
Naftifine HCl Research Workflows
2026-09-15
Naftifine HCl enables mechanism-focused antifungal experiments that connect sterol-biosynthesis inhibition with robust phenotypic and biochemical readouts. This guide provides formulation parameters, assay workflows, troubleshooting strategies, and a careful comparison with the WNT5a/GSK3/β-catenin framework used in muscle progenitor research.